Clinical Trials Directory

Trials / Completed

CompletedNCT02749162

Perineural Dexamethasone in Femural Nerve Block After Ligament Reconstruction

Perineural Dexamethasone Administered in Femural Nerve Block After Anterior Cruciate Ligament Reconstruction

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
90 (actual)
Sponsor
Foisor Orthopedics Clinical Hospital · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

The effect of perineural dexamethasone administered as an adjuvant in prolonging the duration of analgesia continues to be under debate. The investigators performed a prospective randomized study to evaluate the effect of perineural dexamethasone in different concentrations in postoperative analgesia in femoral nerve block for anterior cruciate ligament reconstruction.

Detailed description

After Ethics committee approval, 75 patients American Society of Anesthesiologists score (ASA) I-III were randomized at the end of surgery into 3 groups of 25 patients each who underwent femoral nerve block: group A with 20 ml ropivacaine 0,5% and 20 ml lidocaine 1%; group B with 20 ml ropivacaine 0,5%, 20 ml lidocaine 1% and 4 mg dexamethasone; group C with 20 ml ropivacaine 0,5%, 20 ml lidocaine 1% and 8 mg dexamethasone. All groups received postoperative analgesia when visual analog scale (VAS) over 3 (by request), with IV Perfalgan 1 g and morphine (loading dose 0.1 mg/kg and titration until VAS under 3, followed by subcutaneous (SC) administration of 1/2 of total loading dose on demand for the following 24 hours (h) . Efficacy was evaluated by the time interval from performing the block until the first analgesic dose required, the total amount of morphine in the first 24 h postoperative, the patient satisfaction and the neurological side effects.

Conditions

Interventions

TypeNameDescription
DRUGDexamethasone phosphateAt the end of surgery the patients received single shot VIB block with the mixture according to the group allocation
DRUGParacetamolAfter the block regression, at the first analgetic request the patients received the analgesia protocol
DRUGMorphineAfter the block regression, at the first analgetic request the patients received the analgesia protocol
DRUGLidocaineAt the end of surgery the patients received single shot VIB block with the mixture according to the group allocation
DRUGRopivacaineAt the end of surgery the patients received single shot VIB block with the mixture according to the group allocation

Timeline

Start date
2015-11-01
Primary completion
2017-02-01
Completion
2017-02-01
First posted
2016-04-22
Last updated
2017-08-02

Locations

1 site across 1 country: Romania

Source: ClinicalTrials.gov record NCT02749162. Inclusion in this directory is not an endorsement.